State-of-the-art mitochondrial toxicity prediction.
MitoTox is LiteFold's state-of-the-art model for mitochondrial toxicity prediction, part of our pre-clinical stack (Signal). It helps teams screen liabilities early and run toxicity-aware lead design and optimization.
| System | Score (%) |
|---|---|
| MitoTox (LiteFold) | 82.6 |
| Atom-Pair + GB Baseline | 80.9 |
| Mammoth (LiteFold) | 39.5 |